performed the first randomized, double‐blind, placebo‐controlled clinical trial exploring the modulation of brain‐derived neurotrophic factor (BDNF) in response to Ayahuasca ingestion in patients with depression and controls, and an increase in BDNF was observed in volunteers who ingested Ayahuasca [4]. Here, BDNF is linked to depressive symptom measurement.